Abstract: The invention relates to a water heater comprising a cold water inlet, a hot water outlet, a fluid pathway arranged between the cold water inlet and the hot water outlet, one or more heating elements that heat water in the fluid pathway, a power electronics unit coupled to the one or more heating elements, a controller configured to regulate a temperature of the water in the fluid pathway to an adjustable hot water temperature by controlling the power electronics unit, a flow sensor to detect a water flow through the fluid pathway, and an inlet water temperature sensor adapted to determine an inlet temperature of the water.

Abstract: A multilayer structure including a first layer; a sealant layer formed from one or more ethylene-based polymers; and a cohesive failure layer adjacent to the sealant layer and formed from a polymer blend which comprises an elastomeric propylene based polymer and a second polymer, wherein the second polymer is selected from the group consisting of high pressure low density polyethylene, high density polyethylene, ethylene acrylic acid copolymers, ethylene(meth)acrylic acid copolymers and combinations thereof is provided.

Abstract: A multilayer metallized cast film which includes a first layer which comprises an ethylene-based polymer having a density greater than 0.94 g/cc and a melt index less than or equal to 1.3 g/10 min; and a second layer having an interior surface and an exterior surface and which comprises an ethylene-based polymer having a density greater than 0.94 g/cc and a melt index greater than or equal to 2.0 g/10 min, wherein the exterior surface of the second layer faces away from the first layer, wherein the second layer further comprises a metal and/or metal oxide layer deposited on the exterior surface is provided. Also provided is a packaging comprising the multilayer metallized cast film.

Abstract: A pharmaceutical composition comprises: a) polymorphic form M or tromethamine salt of Compound (1) represented by the following structural formula: and b) a filler. A method of preparing a pharmaceutical composition comprises: providing a mixture of Compound (1) and a filler to form the composition of Compound (1). A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of the pharmaceutical composition.